Ensign Peak Advisors Inc Purchases 2,615 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Ensign Peak Advisors Inc grew its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 7.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 35,741 shares of the company’s stock after acquiring an additional 2,615 shares during the period. Ensign Peak Advisors Inc’s holdings in Molina Healthcare were worth $10,626,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. MQS Management LLC acquired a new stake in Molina Healthcare during the second quarter worth approximately $269,000. XTX Topco Ltd grew its position in shares of Molina Healthcare by 176.2% during the 2nd quarter. XTX Topco Ltd now owns 1,823 shares of the company’s stock worth $542,000 after buying an additional 1,163 shares during the period. Seven Eight Capital LP grew its position in shares of Molina Healthcare by 203.4% during the 2nd quarter. Seven Eight Capital LP now owns 3,808 shares of the company’s stock worth $1,132,000 after buying an additional 2,553 shares during the period. Hsbc Holdings PLC increased its stake in shares of Molina Healthcare by 14.8% in the 2nd quarter. Hsbc Holdings PLC now owns 113,259 shares of the company’s stock valued at $33,726,000 after acquiring an additional 14,563 shares in the last quarter. Finally, Amalgamated Bank lifted its position in shares of Molina Healthcare by 16.0% during the 2nd quarter. Amalgamated Bank now owns 19,177 shares of the company’s stock valued at $5,701,000 after acquiring an additional 2,647 shares during the period. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Trading Down 0.5 %

NYSE MOH opened at $346.29 on Wednesday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $20.29 billion, a P/E ratio of 18.79, a PEG ratio of 1.20 and a beta of 0.57. The business has a fifty day simple moving average of $337.66 and a 200 day simple moving average of $342.19. Molina Healthcare, Inc. has a 12 month low of $282.96 and a 12 month high of $423.92.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. During the same period last year, the firm earned $5.65 earnings per share. The firm’s revenue was up 18.7% on a year-over-year basis. On average, analysts predict that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Insider Transactions at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Stephens restated an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research report on Tuesday, September 10th. Wells Fargo & Company upped their price target on Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft reduced their price objective on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research note on Monday, July 29th. Finally, TD Cowen lowered their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $378.00.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.